公开(公告)号：US20250108018A1

公开(公告)日：2025-04-03

申请号：US18930615

申请日：2024-10-29

Applicant: Monash University

Inventor： Johanna Elisabeth FRASER ,  David Andrew JANS ,  Kylie Michelle WAGSTAFF

IPC: A61K31/167 ,  A61K31/203

Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.

公开(公告)号：US20160074346A1

公开(公告)日：2016-03-17

申请号：US14785059

申请日：2014-04-16

Applicant: Monash University

Inventor： Johanna Elisabeth FRASER ,  David Andrew JANS ,  Kylie Michelle WAGSTAFF

IPC: A61K31/167 ,  A61K31/203

CPC classification number: A61K31/167 ,  A61K31/203 ,  Y02A50/382 ,  Y02A50/385 ,  Y02A50/387 ,  Y02A50/389 ,  Y02A50/393

Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.

Abstract translation: 本发明涉及治疗或预防由诸如登革热病毒，黄热病病毒，西尼罗河病毒或日本脑炎病毒或基孔肯雅病毒（CHIKV）引起的感染引起的病毒感染的方法。 所述方法涉及将具有怀疑患有黄病毒感染或感染CHIKV的受试者或具有被感染黄病毒或被感染CHIKV的风险的受试者施用视黄酸类似物。

公开(公告)号：US20220016057A1

公开(公告)日：2022-01-20

申请号：US17233887

申请日：2021-04-19

Applicant: Monash University

Inventor： Johanna Elisabeth FRASER ,  David Andrew JANS ,  Kylie Michelle WAGSTAFF

IPC: A61K31/167 ,  A61K31/203

Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.

公开(公告)号：US20240016767A1

公开(公告)日：2024-01-18

申请号：US18355802

申请日：2023-07-20

Applicant: Monash University

Inventor： Johanna Elisabeth FRASER ,  David Andrew JANS ,  Kylie Michelle WAGSTAFF

IPC: A61K31/167 ,  A61K31/203

CPC classification number: A61K31/167 ,  A61K31/203 ,  Y02A50/30

Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.